Literature DB >> 28848847

The COPD Pipeline, XXVIII.

Nicholas Gross1,2.   

Abstract

Keywords:  ACOS; JBT-101; OL-BF-001; QBW251; SUN-101; TD-4208; aspirin; danirixin; devices; low-dose theophylline; porous particles; resumab

Year:  2015        PMID： 28848847      PMCID： PMC5556888          DOI： 10.15326/jcopdf.2.3.2015.0149

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN： 2372-952X


× No keyword cloud information.
  4 in total

1.  Large porous particles for pulmonary drug delivery.

Authors:  D A Edwards; J Hanes; G Caponetti; J Hrkach; A Ben-Jebria; M L Eskew; J Mintzes; D Deaver; N Lotan; R Langer
Journal:  Science       Date:  1997-06-20       Impact factor: 47.728

Review 2.  Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises.

Authors:  Francesca Ungaro; Ivana d'Angelo; Agnese Miro; Maria I La Rotonda; Fabiana Quaglia
Journal:  J Pharm Pharmacol       Date:  2012-03-12       Impact factor: 3.765

Review 3.  Recent advances in controlled pulmonary drug delivery.

Authors:  Zhenglin Liang; Rui Ni; Jieyu Zhou; Shirui Mao
Journal:  Drug Discov Today       Date:  2014-10-02       Impact factor: 7.851

4.  Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.

Authors:  Graham Devereux; Seonaidh Cotton; Peter Barnes; Andrew Briggs; Graham Burns; Rekha Chaudhuri; Henry Chrystyn; Lisa Davies; Anthony De Soyza; Shona Fielding; Simon Gompertz; John Haughney; Amanda J Lee; Kirsty McCormack; Gladys McPherson; Alyn Morice; John Norrie; Anita Sullivan; Andrew Wilson; David Price
Journal:  Trials       Date:  2015-06-10       Impact factor: 2.279
  4 in total
  1 in total

1.  A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease.

Authors:  Krishna K Pudi; Chris N Barnes; Edmund J Moran; Brett Haumann; Edward Kerwin
Journal:  Respir Res       Date:  2017-11-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.